<DOC>
	<DOCNO>NCT01099839</DOCNO>
	<brief_summary>This study assess pharmacokinetic interaction ASP1941 Miglitol healthy volunteer .</brief_summary>
	<brief_title>A Study Assess Drug-Drug Interaction Between ASP1941 Miglitol</brief_title>
	<detailed_description>This randomize , open-label , 3-way crossover design study ass drug-drug interaction single oral dose ASP1941 single oral dose Miglitol healthy adult male volunteer . Each subject receive `` ASP1941 alone '' , `` Miglitol alone '' `` ASP1941 + Miglitol '' .</detailed_description>
	<mesh_term>Miglitol</mesh_term>
	<mesh_term>1-Deoxynojirimycin</mesh_term>
	<criteria>Healthy judge investigator/subinvestigator base result physical examination laboratory test Body weight ; ≥50.0 kg , &lt; 80.0 kg Body Mass Index ; ≥17.6 , &lt; 26.4 Written inform consent obtain Received investigational drug within 120 day screen assessment Donated 400 mL whole blood within 90 day , 200 mL whole blood within 30 day , blood component within 14 day screen assessment Received medication within 7 day hospital admission A deviation assessment criterion physical examination laboratory test screen upon admission History drug allergy With renal , hepatic , gastrointestinal , heart , cerebrovascular respiratory diseases Previous treatment ASP1941</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Miglitol</keyword>
</DOC>